Objective: To identify the factors associated with residual C peptide production at least 10 years after diagnosis in children and adolescents with type 1 diabetes. Research design and methods: 73 children and adolescents (<25 years), born in 1988-2005, diagnosed with type 1 diabetes were included during the 4-year study period (2013-2016). At least 10 years after diagnosis, we measured any remaining C peptide concentration using an ultrasensitive C peptide ELISA (>= 1.17pmol/L). The average hemoglobin A1c (HbA1c) was calculated during each of the 10 years after diagnosis and further grand average was calculated for the entire study period. Results: C peptide was detectable in 38% of participants. The C peptide concentration was 4.35....
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
OBJECTIVE: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
BACKGROUND: Stimulated C-peptide measurement after a mixed meal tolerance test (MMTT) is the accepte...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
CONTEXT: Understanding factors involved in the rate of C-peptide decline is needed to tailor therapi...
OBJECTIVE: Small studies using ultrasensitive C-peptide assays suggest endogenous insulin secretion ...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
Objective: To explore whether children diagnosed with type 1 diabetes during islet autoantibody surv...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
OBJECTIVE: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
BACKGROUND: Stimulated C-peptide measurement after a mixed meal tolerance test (MMTT) is the accepte...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
CONTEXT: Understanding factors involved in the rate of C-peptide decline is needed to tailor therapi...
OBJECTIVE: Small studies using ultrasensitive C-peptide assays suggest endogenous insulin secretion ...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
Objective: To explore whether children diagnosed with type 1 diabetes during islet autoantibody surv...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
OBJECTIVE: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...